Stockreport

Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment [Yahoo! Finance]

Alto Neuroscience, Inc.  (ANRO) 
PDF MOUNTAIN VIEW, Calif., February 03, 2026 BUSINESS WIRE )--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the devel [Read more]